Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: A two-year follow-up
- 1 June 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 117 (6) , 1258-1264
- https://doi.org/10.1016/0002-8703(89)90404-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmiasEuropean Heart Journal, 1988
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillationThe American Journal of Cardiology, 1987
- Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetateThe American Journal of Cardiology, 1986
- Long-term antiarrhythmic therapy with flecainideThe American Journal of Cardiology, 1984
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Comparison of Flecainide with Quinidine for Suppression of Chronic Stable Ventricular Ectopic DepolarizationsAnnals of Internal Medicine, 1983
- Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.Circulation, 1982
- Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideThe American Journal of Cardiology, 1981
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981